340B entities face increased challenges in a shifting regulatory and enforcement landscape

[cafead]

via Concerns about who qualifies under the 340B Program, how drugs can be dispensed to patients, and how much entities will be reimbursed may significantly impact the operation of the 340B Program as Congress intended. This evolving landscape poses challenges to all stakeholders.

article source